DEUTSCHE BANK AG\ - MABVAX THERAPEUTICS HLDGS IN ownership

MABVAX THERAPEUTICS HLDGS IN's ticker is MBVXQ and the CUSIP is 55414P702. A total of 15 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MABVAX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2018$010.00%
Other shareholders

There were no reported owners of MABVAX THERAPEUTICS HLDGS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of MABVAX THERAPEUTICS HLDGS IN shareholders